|Dr. Glynn Wilson Ph.D.||Chief Science Officer & Chairman||4k||N/A||1947|
|Mr. Brian Scott John||CEO & Exec. Director||223.58k||N/A||1969|
|Mr. Richard A. Miller||Chief Compliance Officer & Director||124k||N/A||1968|
|Mr. Douglas O. McKinnon||Chief Financial Officer||N/A||N/A||1951|
|Mr. Ryan T. Allison||Chief Operating Officer||N/A||N/A||N/A|
Jupiter Wellness, Inc. develops cannabidiol (CBD) based medical therapeutics and wellness products. The company's clinical pipeline includes CaniDermRX (JW-100), a novel topical formulation containing CBD and aspartame for use in the treatment of eczema, dermatitis, and actinic keratosis; JW-101, a prescription product for the treatment of burns; and JW-200, a non-prescription lotion/lip balm for the treatment of symptoms of cold sores. It also manufactures, distributes, and markets a line of consumer products, such as CaniSun, a CBD-infused sunscreen; and CaniSkin, a CBD-infused skin care lotion. The company was formerly known as CBD Brands, Inc. Jupiter Wellness, Inc. was incorporated in 2018 and is headquartered in Jupiter, Florida.
Jupiter Wellness, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.